Atopic dermatitis Yardstick: A new era of topical and systemic treatments

Document Type

Journal Article

Publication Date

6-1-2026

Journal

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

DOI

10.1016/j.anai.2026.05.028

Abstract

The atopic dermatitis (AD) Yardstick articles aim to provide an up-to-date review of AD therapy for clinicians. The first 2 AD Yardstick articles were published in 2018 and 2023. Since the last update, multiple medications have been added to the armamentarium of AD. These include roflumilast cream, tapinarof cream, lebrikizumab, and nemolizumab. In the current AD Yardstick article, we aim to provide evidence-based information on these new treatments and updated information on previously reviewed therapies. A new feature of the AD Yardstick article is the addition of patient vignettes, which provide a practical guide and clinical pearls for clinicians.

Department

Dermatology

Share

COinS